[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:

View post   
>> No.20713781 [View]
File: 274 KB, 1080x1232, original_222154910.png [View same] [iqdb] [saucenao] [google]
20713781

Wtf is this?

https://stocktwits.com/symbol/KTOV
https://stocktwits.com/symbol/KTOV
https://stocktwits.com/symbol/KTOV

>> No.19914616 [View]
File: 274 KB, 1080x1232, original_222154910.png [View same] [iqdb] [saucenao] [google]
19914616

Sigh...

Sigh...


Sigh...
Sigh... One last DD post for ya’ll before the AH explosion...

1. NT-219 commercialized through partnerships in the US, China, and Korea.

2. Cetuximab was developed in collaboration with Merck and Bristol-Meyers Squibb

3. NT-219 study with cetuximab is licensed under Merck

4. 6/22/20 Merck’s Keytruda
approved for treatment in China

5. Keytruda is a key oncology therapy that will validate use of NT-219.

5. KITOV announces partnership by June 30 for NT-219.

I strongly feel that the partnership is with Merck and that the approval for use of Keytruda in China was needed prior to releasing the PR.

GLTA

>> No.19891095 [View]
File: 274 KB, 1080x1232, 4ICXmZD.png [View same] [iqdb] [saucenao] [google]
19891095

KTOV volume 310 milliion fucking unreal

Won't sell a single share until SP $7 - they have 70m cash now and Mcap is less than the cash they have on hand.

>> No.19884491 [View]
File: 274 KB, 1080x1232, 4ICXmZD.png [View same] [iqdb] [saucenao] [google]
19884491

Navigation
View posts[+24][+48][+96]